Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01041911Phase 2Completed
Phase 2, randomised, double-blind trial of euphorbia prostrata extract in Hemorrhoids (4 arms), sponsored by Panacea Biotec. Primary endpoint: Proportion of subjects achieving cessation of per rectal bleeding at 14 days. Started Mar 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01041911.